Novo Nordisk’s Wegovy Wins EMA Flexibility In GLP-1 Access Push
Find your next quality investment with Simply Wall St’s easy and powerful screener, trusted by over 7 million…
What Novo Nordisk (CPSE:NOVO B)’s Higher-Dose, Lower-Priced Wegovy Move Means For Shareholders
In recent weeks, Novo Nordisk has rolled out a higher-dose 7.2 mg Wegovy injection in the US at…
Novo Nordisk launches Wegovy subscription program
Novo Nordisk launched a multi-month subscription program for its Wegovy obesity drug on March 31, offering eligible self-pay…